Conmed (CNMD) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $46.22 -1.51%
EPS Growth %: -7.4%
Financial Fact:
Cost of sales: 83.58M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -7.4%
Financial Fact:
Cost of sales: 83.58M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q4 EPS of $0.54, $0.02 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $204.1 million versus the consensus estimate of $204.04 million.
Expects FY 2017 sales to grow 1-3% on constant currency basis
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Skillsoft (SKIL) Tops Q2 EPS by 14c; Offers Guidance
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
